Skip to main content

Table 3 General health score and general health score component frequency within the validation/test population

From: Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs

  General disease status group
Low tertile Medium tertile High tertile
Patients, n 4400 3426 3559
General health score
 Mean (SD) 0.00 (0.00) 5.72 (0.31) 16.07 (7.22)
 Median (IQR) 0.00 (0.00–0.00) 5.78 (5.42–5.89) 12.14 (11.13–17.46)
 Minimum 0 5.24 8.94
 Maximum 0 6.25 64.82
General health score components, n (%)
 Myocardial infarction 0 0 47 (1.3)
 Metastatic solid tumor 0 0 45 (1.3)
 Any primary malignancy 0 0 363 (10.2)
 Drug/device complication 0 0 658 (18.5)
 Diabetes with chronic complications 0 0 159 (4.5)
 Hematologic 0 329 (9.6) 1038 (29.2)
 Gastrointestinal disease 0 1033 (30.2) 2301 (64.7)
 Psychiatric 0 1190 (34.7) 2090 (58.7)
 Rheumatologic 0 31 (0.9) 125 (3.5)
 Genitourinary 0 843 (24.6) 1876 (52.7)
  1. IQR interquartile range, MS multiple sclerosis, SD standard deviation